SDZ-218-135

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSDZ-218-135
Drug Alias NameSDZ-218-135
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels stimulants
TargetsSodium channels
Therapy Area/IndicationsHeart FailureArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSandoz Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSandoz Pharmaceuticals Ag
Active IndicationsN/A
Inactive IndicationsHeart FailureArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A